Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.805 USD | +7.33% | +2.48% | +7.50% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.50% | 20.26M | |
+14.76% | 109B | |
-0.29% | 29.49B | |
+13.59% | 23.1B | |
-11.96% | 18.52B | |
-6.80% | 17.38B | |
+17.06% | 16.24B | |
-4.20% | 12.29B | |
0.00% | 10.63B | |
-9.05% | 9.52B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Unit, ENSCO Sign Drone Acquisition Deal